换一批
换一批Comparison of GeneChip, nCounter, and Real-Time PCR-Based Gene Expressions Predicting Locoregional Tumor Control after Primary and Postoperative Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
作者：
Stefan,Schmidt [1]
;
Annett,Linge [2]
;
Marianne,Grosser [3]
;
Fabian,Lohaus [4]
;
Volker,Gudziol [5]
;
Alexander,Nowak [6]
;
Ingeborg,Tinhofer [7]
;
Volker,Budach [7]
;
Ali,Sak [8]
;
Martin,Stuschke [8]
;
Panagiotis,Balermpas [9]
;
Claus,Rödel [9]
;
Henning,Schäfer [10]
;
Anca-Ligia,Grosu [10]
;
Amir,Abdollahi [11]
;
Jürgen,Debus [12]
;
Ute,Ganswindt [13]
;
Claus,Belka [14]
;
Steffi,Pigorsch [15]
;
Stephanie E,Combs [16]
;
David,Mönnich [17]
;
Daniel,Zips [18]
;
Gustavo B,Baretton [19]
;
Frank,Buchholz [20]
;
Michael,Baumann [21]
;
Mechthild,Krause [22]
;
Steffen,Löck [4]
;
German Cancer Consortium Radiation Oncology Group
作者单位：
German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg; the OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology-OncoRay, Dresden, Germany.
[1]
German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg; the OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany. Electronic address: annett.linge@uniklinikum-dresden.de.
[2]
Institute of Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
[3]
German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg; the OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
[4]
National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Department of Otorhinolaryngology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
[5]
National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Department of Oral and Maxillofacial Surgery, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
[6]
German Cancer Consortium (DKTK) partner site Berlin, Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiooncology and Radiotherapy, Charité University Medicine Berlin, Berlin, Germany.
[7]
German Cancer Consortium (DKTK) partner site Essen, Essen and the German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
[8]
German Cancer Consortium (DKTK) partner site Frankfurt, Frankfurt and the German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany.
[9]
German Cancer Consortium (DKTK) partner site Freiburg, Freiburg and the German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, Medical Center, Medical Faculty, University of Freiburg, Freiburg, Germany.
[10]
German Cancer Consortium (DKTK) partner site Heidelberg, Heidelberg and the German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, National Center for Radiation Research in Oncology, University of Heidelberg Medical School and German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Ion Therapy Center, Department of Radiation Oncology, University of Heidelberg Medical School, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg Medical School and German Cancer Research Center (DKFZ), Heidelberg, Germany; Translational Radiation Oncology, University of Heidelberg Medical School and German Cancer Research Center (DKFZ), Heidelberg, Germany.
[11]
German Cancer Consortium (DKTK) partner site Heidelberg, Heidelberg and the German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Institute of Radiation Oncology, National Center for Radiation Research in Oncology, University of Heidelberg Medical School and German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Ion Therapy Center, Department of Radiation Oncology, University of Heidelberg Medical School, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg Medical School and German Cancer Research Center (DKFZ), Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, University of Heidelberg Medical School and German Cancer Research Center (DKFZ), Heidelberg, Germany.
[12]
German Cancer Consortium (DKTK) partner site Munich, Munich, Germany; Department of Radiotherapy and Radiation Oncology, University Hospital, Ludwig-Maximilians-Universität, Munich, Germany.
[13]
German Cancer Consortium (DKTK) partner site Munich, Munich, Germany; Department of Radiotherapy and Radiation Oncology, University Hospital, Ludwig-Maximilians-Universität, Munich, Germany; Clinical Cooperation Group Personalized Radiotherapy in Head and Neck Cancer, Helmholtz Zentrum Munich, Neuherberg, Germany.
[14]
German Cancer Consortium (DKTK) partner site Munich, Munich, Germany; Department of Radiation Oncology, Technische Universität München, Munich, Germany.
[15]
German Cancer Consortium (DKTK) partner site Munich, Munich, Germany; Department of Radiation Oncology, Technische Universität München, Munich, Germany; Department of Radiation Sciences, Institut für Innovative Radiotherapie (iRT), Helmholtz Zentrum Munich, Neuherberg, Germany.
[16]
German Cancer Consortium (DKTK) partner site Tübingen, Tübingen and the German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Radiation Oncology, Faculty of Medicine and University Hospital Tübingen, Eberhard Karls Universität Tübingen, Tübingen, Germany.
[17]
German Cancer Consortium (DKTK) partner site Tübingen, Tübingen and the German Cancer Research Center (DKFZ), Heidelberg, Germany; Tumour and Normal Tissue Bank, University Cancer Centre, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
[18]
German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; Institute of Pathology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Tumour and Normal Tissue Bank, University Cancer Centre, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
[19]
German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany; University Cancer Centre, Medical Systems Biology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
[20]
German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg; the OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology-OncoRay, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.
[21]
German Cancer Consortium (DKTK) partner site Dresden, Dresden, Germany; German Cancer Research Center (DKFZ), Heidelberg; the OncoRay-National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology-OncoRay, Dresden, Germany; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, and Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
[22]
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);女(雌)性(Female);随访研究(Follow-Up Studies);基因表达(Gene Expression);基因表达谱(Gene Expression Profiling);头颈部肿瘤(Head and Neck Neoplasms);人类(Humans);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);寡核苷酸序列分析(Oligonucleotide Array Sequence Analysis);预后(Prognosis);回顾性研究(Retrospective Studies);青年人(Young Adult)
DOI
10.1016/j.jmoldx.2020.03.005
PMID
32247864
发布时间
2021-07-30
- 浏览31
The Journal of molecular diagnostics
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
